Antonella Pietragalla

14PUBLICATIONS
26CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 01, 2022
Integration of PARP-inhibitors in ovarian cancer therapy.

Antonella Pietragalla, Francesca Ciccarone, Camilla Nero

|Sep 01, 2022
Immunotherapy in gynecological cancers.

Domenica Lorusso, Valentina Ceni, Gennaro Daniele

|Aug 26, 2022
BRCA testing on buccal swab to improve access to healthcare and cancer prevention: a performance evaluation.

Elisa De Paolis, Alessia Perrucci, Claudia Marchetti

|Feb 25, 2022
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years.

Rosa Falcone, Pasquale Lombardi, Marco Filetti

|Oct 23, 2021
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials.

Simona Duranti, Alessandra Fabi, Marco Filetti

|Jul 02, 2021
Oligometastatic Breast Cancer: How to Manage It?

Vittoria Barberi, Antonella Pietragalla, Gianluca Franceschini

Pageof 3

Frequent Collaborators

6 joint publications

Gennaro Daniele

5 joint publications

Anna Fagotti

4 joint publications

Simona Duranti

4 joint publications

Camilla Nero